Dr. Ryckman is a perinatal epidemiologist with expertise in statistics, genetics, and metabolomics.
Her current work focuses broadly on two areas:
- neonatal morbidity and mortality and
- maternal morbidity and mortality.
An ongoing project is to use targeted metabolic profiling to predict major neonatal morbidity and mortality in babies born less than 32 weeks gestation. She is also examining how neonatal metabolic profiles can predict neurodevelopmental, spatial and numerical skills and respiratory and cardiovascular outcomes in babies born preterm. Her current work on maternal morbidity and mortality has been focused on four areas:
- improving data measurement and reporting,
- identifying obstetrical and health system risk factors,
- examining social determinants and disparities including maternal mental health, and
- engaging community and stakeholder perspectives in implementation of interventions.
General research interests: genetics, metabolomics and developmental origins of chronic disease Specific interests: preterm birth, complications of preterm birth and diabetes Programmatic interests: Newborn screening, prenatal screening, biobanks.
